Itzhak Goldberg - 24 Jun 2021 Form 4 Insider Report for Angion Biomedica Corp. (ELTX)

Role
Executive Chairman and Chief Scientific Officer
Signature
/s/ Jennifer J. Rhodes, as attorney-in fact for Itzhak Goldberg
Issuer symbol
ELTX
Transactions as of
24 Jun 2021
Net transactions value
-$1,282,361
Form type
4
Filing time
17 Nov 2021, 17:02:23 UTC
Next filing
03 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELTX Common Stock Tax liability $653,310 -47,410 -2.3% $13.78 2,020,068 24 Jun 2021 Direct F1
transaction ELTX Common Stock Sale $465,243 -111,505 -5.5% $4.17 1,908,563 15 Nov 2021 Direct F2, F3
transaction ELTX Common Stock Sale $163,808 -38,495 -2% $4.26 1,870,068 16 Nov 2021 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were withheld to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs").
F2 The shares reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2021 by the Reporting Person
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.48 inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.21 to $4.38 inclusive.

Remarks:

Executive Chairman and Chief Scientific Officer